Table 3 Summary of the secondary outcomes of the study
Corticosteroids (n = 1117) | No corticosteroids (n = 463) | P value | |
|---|---|---|---|
Secondary outcomes | |||
In-hospital mortality | 428 (38.3%) | 153 (33.0%) | 0.05 |
Hospital LOS (days) | |||
Overall | 30 (21–46) | 30 (18–46) | 0.63 |
Survivors | 37 (25–53) | 38 (25–52) | 0.70 |
Non-survivors | 24 (15–33) | 14 (9–24) | < 0.001 |
Ventilator-free days at 28 days | 8.2 ± 9.2 | 7.5 ± 8.6 | 0.17 |
ICU LOS (days) | |||
Overall | 19 (11–31) | 17 (10–31) | 0.04 |
Survivors | 18 (12–33) | 20 (12–31) | 0.82 |
Non-survivors | 19 (11–29) | 12 (6–23) | < 0.001 |
Ventilator-associated pneumonia | 225 (20.1%) | 90 (19.4%) | 0.83 |